News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,153 Results
Type
Article (40725)
Company Profile (264)
Press Release (672156)
Multimedia
Podcasts (73)
Webinars (17)
Section
Business (204621)
Career Advice (2030)
Deals (35504)
Drug Delivery (99)
Drug Development (81362)
Employer Resources (174)
FDA (16351)
Job Trends (14943)
News (346256)
Policy (32739)
Tag
Academia (2562)
Accelerated approval (15)
Adcomms (24)
Allergies (115)
Alliances (49614)
ALS (133)
Alzheimer's disease (1558)
Antibody-drug conjugate (ADC) (218)
Approvals (16446)
Artificial intelligence (391)
Autoimmune disease (67)
Automation (27)
Bankruptcy (361)
Best Places to Work (11644)
BIOSECURE Act (20)
Biosimilars (149)
Biotechnology (175)
Bladder cancer (128)
Brain cancer (45)
Breast cancer (483)
Cancer (3758)
Cardiovascular disease (298)
Career advice (1707)
Career pathing (33)
CAR-T (221)
CDC (42)
Cell therapy (596)
Cervical cancer (31)
Clinical research (68169)
Collaboration (1285)
Company closure (4)
Compensation (910)
Complete response letters (44)
COVID-19 (2680)
CRISPR (70)
C-suite (554)
Cystic fibrosis (128)
Data (4463)
Decentralized trials (2)
Denatured (22)
Depression (93)
Diabetes (416)
Diagnostics (6534)
Digital health (33)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (183)
Drug pricing (154)
Drug shortages (28)
Duchenne muscular dystrophy (192)
Earnings (88770)
Editorial (45)
Employer branding (22)
Employer resources (152)
Events (115298)
Executive appointments (924)
FDA (18742)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1168)
Gene editing (155)
Generative AI (30)
Gene therapy (473)
GLP-1 (863)
Government (4608)
Grass and pollen (5)
Guidances (347)
Healthcare (18858)
HIV (42)
Huntington's disease (34)
IgA nephropathy (59)
Immunology and inflammation (204)
Immuno-oncology (16)
Indications (52)
Infectious disease (2900)
Inflammatory bowel disease (170)
Inflation Reduction Act (13)
Influenza (91)
Intellectual property (184)
Interviews (320)
IPO (16616)
IRA (48)
Job creations (3655)
Job search strategy (1434)
Kidney cancer (15)
Labor market (72)
Layoffs (537)
Leadership (27)
Legal (7959)
Liver cancer (87)
Longevity (11)
Lung cancer (542)
Lymphoma (261)
Machine learning (29)
Management (59)
Manufacturing (572)
MASH (130)
Medical device (13608)
Medtech (13631)
Mergers & acquisitions (19751)
Metabolic disorders (1024)
Multiple sclerosis (132)
NASH (16)
Neurodegenerative disease (198)
Neuropsychiatric disorders (49)
Neuroscience (2501)
NextGen: Class of 2025 (6524)
Non-profit (4496)
Now hiring (58)
Obesity (481)
Opinion (244)
Ovarian cancer (133)
Pain (149)
Pancreatic cancer (165)
Parkinson's disease (225)
Partnered (27)
Patents (399)
Patient recruitment (309)
Peanut (53)
People (58275)
Pharmaceutical (63)
Pharmacy benefit managers (23)
Phase I (21209)
Phase II (30006)
Phase III (22383)
Pipeline (2666)
Policy (243)
Postmarket research (2569)
Preclinical (9024)
Press Release (64)
Prostate cancer (189)
Psychedelics (42)
Radiopharmaceuticals (256)
Rare diseases (593)
Real estate (5944)
Recruiting (70)
Regulatory (23472)
Reports (51)
Research institute (2355)
Resumes & cover letters (352)
Rett syndrome (15)
RNA editing (11)
RSV (66)
Schizophrenia (123)
Series A (191)
Series B (147)
Service/supplier (11)
Sickle cell disease (74)
Special edition (20)
Spinal muscular atrophy (150)
Sponsored (34)
Startups (3605)
State (2)
Stomach cancer (14)
Supply chain (92)
Tariffs (79)
The Weekly (49)
Vaccines (904)
Venture capital (63)
Weight loss (310)
Women's health (54)
Worklife (17)
Date
Last 7 days (685)
Last 30 days (2304)
Last 365 days (30445)
2025 (24521)
2024 (35237)
2023 (40091)
2022 (51199)
2021 (55732)
2020 (54099)
2019 (46577)
2018 (35052)
2017 (32150)
2016 (31509)
2015 (37568)
2014 (31334)
2013 (26378)
2012 (28602)
2011 (29309)
2010 (27345)
Location
Africa (731)
Alabama (71)
Alaska (7)
Arizona (267)
Arkansas (13)
Asia (38681)
Australia (6327)
California (9147)
Canada (2815)
China (836)
Colorado (384)
Connecticut (392)
Delaware (254)
Europe (83323)
Florida (1365)
Georgia (296)
Hawaii (2)
Idaho (60)
Illinois (709)
India (45)
Indiana (437)
Iowa (18)
Japan (315)
Kansas (118)
Kentucky (33)
Louisiana (17)
Maine (68)
Maryland (1201)
Massachusetts (6680)
Michigan (280)
Minnesota (527)
Mississippi (4)
Missouri (109)
Montana (29)
Nebraska (25)
Nevada (103)
New Hampshire (71)
New Jersey (2515)
New Mexico (28)
New York (2485)
North Carolina (1246)
North Dakota (8)
Northern California (4240)
Ohio (278)
Oklahoma (20)
Oregon (36)
Pennsylvania (1925)
Puerto Rico (18)
Rhode Island (43)
South America (1102)
South Carolina (48)
South Dakota (1)
Southern California (3519)
Tennessee (146)
Texas (1414)
United States (33172)
Utah (270)
Virginia (219)
Washington D.C. (77)
Washington State (763)
West Virginia (4)
Wisconsin (78)
Wyoming (1)
713,153 Results for "genentech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immuno-oncology
Genentech Walks Away From $2B Partnership With Adaptive Biotechnologies
Adaptive and Genentech first partnered in 2018 to advance T cell receptor-based therapies for cancer.
August 19, 2025
·
1 min read
·
Tristan Manalac
Layoffs
Genentech Downsizes by 87 as Priorities Shift
The latest round of terminations, which will take effect Sept. 15, comes after Genentech fired more than 500 employees in the last 15 months.
July 24, 2025
·
2 min read
·
Tristan Manalac
Press Releases
FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis
October 20, 2025
·
12 min read
Press Releases
Genentech’s Tecentriq Showed Significant Overall and Disease-Free Survival Benefits in Bladder Cancer With ctDNA-Guided Treatment
October 20, 2025
·
12 min read
Press Releases
Genentech’s Phase III evERA Data Showed Giredestrant Significantly Improved Progression-Free Survival in People With ER-Positive Advanced Breast Cancer
October 20, 2025
·
8 min read
Press Releases
FDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
October 3, 2025
·
11 min read
Press Releases
Starpharma Announces a Collaboration and License Agreement with Genentech
September 23, 2025
·
2 min read
Earnings
‘We’re Not Done’: Roche Plans To Sustain Dealmaking Pace After 89bio
Roche has already signed several high-ticket deals this year, including the $3.5 billion acquisition of 89bio and Genentech’s $2.1 billion molecular glue pact with Orionis Biosciences.
October 23, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Positive Phase III Results Show Genentech’s Giredestrant Significantly Improved Progression-Free Survival in ER-positive Advanced Breast Cancer
September 22, 2025
·
7 min read
Press Releases
New Data for Genentech’s Vabysmo Reinforce Its Efficacy, Safety and Durability in Wet Age-Related Macular Degeneration (AMD)
September 5, 2025
·
9 min read
1 of 71,316
Next
